Stay updated on Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-28T23:07:05.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A notice was added about NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The study record itself remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-21T23:04:02.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-14T23:06:26.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The site revision indicator changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-10-07T23:10:21.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now returns a 403 Forbidden error, replacing the previously visible study details with an error screen. This indicates that the study record content is no longer accessible due to a permissions issue.
    Difference
    21%
    Check dated 2026-09-23T23:06:25.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0, indicating a newer release of the page content. This update appears to reflect internal updates or bug fixes rather than changes to the study details shown.
    Difference
    0.0%
    Check dated 2026-09-16T22:27:21.000Z thumbnail image

Stay in the know with updates to Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combinations in EGFR/ALK NSCLC Clinical Trial page.